Annual CFO
$139.96 M
-$124.51 M-47.08%
31 December 2023
Summary:
Integra LifeSciences Holdings annual cash flow from operations is currently $139.96 million, with the most recent change of -$124.51 million (-47.08%) on 31 December 2023. During the last 3 years, it has fallen by -$63.88 million (-31.34%). IART annual CFO is now -55.20% below its all-time high of $312.43 million, reached on 31 December 2021.IART Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$22.48 M
-$17.92 M-44.35%
30 September 2024
Summary:
Integra LifeSciences Holdings quarterly cash flow from operations is currently $22.48 million, with the most recent change of -$17.92 million (-44.35%) on 30 September 2024. Over the past year, it has dropped by -$4.29 million (-16.01%). IART quarterly CFO is now -75.37% below its all-time high of $91.29 million, reached on 30 June 2021.IART Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$137.39 M
-$4.29 M-3.02%
30 September 2024
Summary:
Integra LifeSciences Holdings TTM cash flow from operations is currently $137.39 million, with the most recent change of -$4.29 million (-3.02%) on 30 September 2024. Over the past year, it has dropped by -$29.15 million (-17.50%). IART TTM CFO is now -57.52% below its all-time high of $323.41 million, reached on 30 September 2021.IART TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IART Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.1% | -16.0% | -17.5% |
| 3 y3 years | -31.3% | -72.8% | -57.5% |
| 5 y5 years | -29.9% | -65.0% | -25.7% |
IART Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -55.2% | at low | -73.7% | +42.7% | -57.5% | +6.0% |
| 5 y | 5 years | -55.2% | at low | -75.4% | +42.7% | -57.5% | +6.0% |
| alltime | all time | -55.2% | +1526.1% | -75.4% | +648.4% | -57.5% | +1360.5% |
Integra LifeSciences Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $22.48 M(-44.3%) | $137.39 M(-3.0%) |
| June 2024 | - | $40.40 M(+156.4%) | $141.68 M(+9.4%) |
| Mar 2024 | - | $15.76 M(-73.2%) | $129.56 M(-7.4%) |
| Dec 2023 | $139.96 M(-47.1%) | $58.75 M(+119.5%) | $139.96 M(-16.0%) |
| Sept 2023 | - | $26.77 M(-5.3%) | $166.54 M(-20.0%) |
| June 2023 | - | $28.28 M(+8.1%) | $208.08 M(-15.5%) |
| Mar 2023 | - | $26.16 M(-69.3%) | $246.28 M(-6.9%) |
| Dec 2022 | $264.47 M(-15.4%) | $85.33 M(+24.9%) | $264.47 M(+6.5%) |
| Sept 2022 | - | $68.31 M(+2.8%) | $248.41 M(-5.5%) |
| June 2022 | - | $66.48 M(+49.9%) | $262.88 M(-8.6%) |
| Mar 2022 | - | $44.34 M(-36.0%) | $287.69 M(-7.9%) |
| Dec 2021 | $312.43 M(+53.3%) | $69.28 M(-16.3%) | $312.43 M(-3.4%) |
| Sept 2021 | - | $82.78 M(-9.3%) | $323.41 M(+4.2%) |
| June 2021 | - | $91.29 M(+32.1%) | $310.27 M(+23.1%) |
| Mar 2021 | - | $69.08 M(-13.9%) | $252.10 M(+23.7%) |
| Dec 2020 | $203.83 M(-11.9%) | $80.26 M(+15.3%) | $203.83 M(-4.2%) |
| Sept 2020 | - | $69.64 M(+110.3%) | $212.75 M(+2.6%) |
| June 2020 | - | $33.12 M(+59.1%) | $207.36 M(-6.9%) |
| Mar 2020 | - | $20.81 M(-76.7%) | $222.76 M(-3.7%) |
| Dec 2019 | $231.43 M(+15.9%) | $89.18 M(+38.8%) | $231.43 M(+25.1%) |
| Sept 2019 | - | $64.24 M(+32.4%) | $184.94 M(-7.5%) |
| June 2019 | - | $48.52 M(+64.6%) | $199.95 M(+6.6%) |
| Mar 2019 | - | $29.48 M(-30.9%) | $187.64 M(-6.0%) |
| Dec 2018 | $199.68 M(+74.3%) | $42.69 M(-46.1%) | $199.68 M(+18.5%) |
| Sept 2018 | - | $79.25 M(+118.8%) | $168.54 M(+25.3%) |
| June 2018 | - | $36.21 M(-12.8%) | $134.53 M(+5.8%) |
| Mar 2018 | - | $41.53 M(+259.6%) | $127.19 M(+11.0%) |
| Dec 2017 | $114.54 M(-1.6%) | $11.55 M(-74.5%) | $114.54 M(+4.6%) |
| Sept 2017 | - | $45.24 M(+56.7%) | $109.52 M(-1.4%) |
| June 2017 | - | $28.87 M(-0.0%) | $111.05 M(-7.7%) |
| Mar 2017 | - | $28.88 M(+342.4%) | $120.26 M(+3.3%) |
| Dec 2016 | $116.41 M(+11.0%) | $6.53 M(-86.0%) | $116.41 M(-14.1%) |
| Sept 2016 | - | $46.77 M(+22.8%) | $135.52 M(+25.1%) |
| June 2016 | - | $38.08 M(+52.1%) | $108.36 M(+10.3%) |
| Mar 2016 | - | $25.03 M(-2.4%) | $98.27 M(-6.3%) |
| Dec 2015 | $104.85 M(+25.5%) | $25.64 M(+30.7%) | $104.85 M(+0.8%) |
| Sept 2015 | - | $19.61 M(-29.9%) | $104.07 M(-9.9%) |
| June 2015 | - | $27.98 M(-11.5%) | $115.54 M(+11.2%) |
| Mar 2015 | - | $31.62 M(+27.2%) | $103.93 M(+24.4%) |
| Dec 2014 | $83.56 M(+56.9%) | $24.86 M(-20.0%) | $83.56 M(+18.7%) |
| Sept 2014 | - | $31.07 M(+89.7%) | $70.40 M(+0.4%) |
| June 2014 | - | $16.38 M(+45.5%) | $70.14 M(+23.7%) |
| Mar 2014 | - | $11.25 M(-3.8%) | $56.68 M(+6.4%) |
| Dec 2013 | $53.27 M(-9.9%) | $11.70 M(-62.0%) | $53.27 M(+39.6%) |
| Sept 2013 | - | $30.81 M(+955.8%) | $38.17 M(+8.2%) |
| June 2013 | - | $2.92 M(-62.8%) | $35.27 M(+1.9%) |
| Mar 2013 | - | $7.85 M(-330.6%) | $34.63 M(-41.4%) |
| Dec 2012 | $59.10 M(-43.4%) | -$3.40 M(-112.2%) | $59.10 M(-39.2%) |
| Sept 2012 | - | $27.91 M(+1126.2%) | $97.20 M(+4.4%) |
| June 2012 | - | $2.28 M(-93.0%) | $93.08 M(-19.3%) |
| Mar 2012 | - | $32.32 M(-6.9%) | $115.39 M(+10.6%) |
| Dec 2011 | $104.33 M(-1.2%) | $34.70 M(+45.8%) | $104.33 M(+6.4%) |
| Sept 2011 | - | $23.80 M(-3.2%) | $98.06 M(-5.6%) |
| June 2011 | - | $24.58 M(+15.7%) | $103.91 M(+5.3%) |
| Mar 2011 | - | $21.25 M(-25.2%) | $98.69 M(-6.5%) |
| Dec 2010 | $105.57 M | $28.43 M(-4.1%) | $105.57 M(-15.0%) |
| Sept 2010 | - | $29.65 M(+53.1%) | $124.19 M(+1.0%) |
| June 2010 | - | $19.36 M(-31.2%) | $122.91 M(-8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $28.14 M(-40.2%) | $134.19 M(-6.3%) |
| Dec 2009 | $143.24 M(+97.3%) | $47.04 M(+65.8%) | $143.24 M(+16.2%) |
| Sept 2009 | - | $28.37 M(-7.4%) | $123.28 M(+1.0%) |
| June 2009 | - | $30.64 M(-17.6%) | $122.04 M(+36.5%) |
| Mar 2009 | - | $37.19 M(+37.3%) | $89.43 M(+23.2%) |
| Dec 2008 | $72.59 M(+54.4%) | $27.09 M(-0.1%) | $72.59 M(+20.8%) |
| Sept 2008 | - | $27.13 M(-1473.6%) | $60.09 M(+37.7%) |
| June 2008 | - | -$1.98 M(-109.7%) | $43.64 M(-16.2%) |
| Mar 2008 | - | $20.35 M(+39.4%) | $52.09 M(+10.8%) |
| Dec 2007 | $47.03 M(-34.4%) | $14.59 M(+36.7%) | $47.03 M(-11.9%) |
| Sept 2007 | - | $10.67 M(+64.7%) | $53.37 M(-20.5%) |
| June 2007 | - | $6.48 M(-57.6%) | $67.14 M(-11.8%) |
| Mar 2007 | - | $15.28 M(-27.0%) | $76.11 M(+6.2%) |
| Dec 2006 | $71.70 M(+26.1%) | $20.93 M(-14.3%) | $71.70 M(+9.1%) |
| Sept 2006 | - | $24.44 M(+58.1%) | $65.73 M(+22.4%) |
| June 2006 | - | $15.46 M(+42.2%) | $53.69 M(-1.5%) |
| Mar 2006 | - | $10.87 M(-27.3%) | $54.49 M(-4.2%) |
| Dec 2005 | $56.85 M(+45.9%) | $14.96 M(+20.7%) | $56.85 M(+16.3%) |
| Sept 2005 | - | $12.40 M(-23.7%) | $48.88 M(+2.7%) |
| June 2005 | - | $16.26 M(+22.9%) | $47.59 M(+15.1%) |
| Mar 2005 | - | $13.23 M(+89.3%) | $41.36 M(+6.1%) |
| Dec 2004 | $38.98 M(+11.9%) | $6.99 M(-37.1%) | $38.98 M(+9.3%) |
| Sept 2004 | - | $11.11 M(+10.8%) | $35.65 M(+9.3%) |
| June 2004 | - | $10.03 M(-7.6%) | $32.61 M(-11.5%) |
| Mar 2004 | - | $10.85 M(+196.0%) | $36.85 M(+5.8%) |
| Dec 2003 | $34.83 M(+8.9%) | $3.67 M(-54.6%) | $34.83 M(-18.4%) |
| Sept 2003 | - | $8.07 M(-43.4%) | $42.66 M(-0.3%) |
| June 2003 | - | $14.26 M(+61.6%) | $42.78 M(+21.3%) |
| Mar 2003 | - | $8.83 M(-23.2%) | $35.27 M(+10.3%) |
| Dec 2002 | $31.98 M(+103.7%) | $11.50 M(+40.3%) | $31.98 M(+17.8%) |
| Sept 2002 | - | $8.19 M(+21.3%) | $27.16 M(+8.6%) |
| June 2002 | - | $6.75 M(+21.9%) | $25.01 M(+49.8%) |
| Mar 2002 | - | $5.54 M(-17.0%) | $16.69 M(+6.3%) |
| Dec 2001 | $15.70 M(-416.6%) | $6.67 M(+10.4%) | $15.70 M(+107.6%) |
| Sept 2001 | - | $6.04 M(-485.9%) | $7.56 M(+142.7%) |
| June 2001 | - | -$1.57 M(-134.4%) | $3.12 M(+266.7%) |
| Mar 2001 | - | $4.55 M(-411.0%) | $850.00 K(-117.1%) |
| Dec 2000 | -$4.96 M(-298.2%) | -$1.46 M(-191.7%) | -$4.96 M(+148.6%) |
| Sept 2000 | - | $1.60 M(-141.6%) | -$2.00 M(-52.4%) |
| June 2000 | - | -$3.83 M(+204.2%) | -$4.19 M(-206.3%) |
| Mar 2000 | - | -$1.26 M(-183.9%) | $3.94 M(+57.6%) |
| Dec 1999 | $2.50 M(-125.5%) | $1.50 M(-350.3%) | $2.50 M(-224.2%) |
| Sept 1999 | - | -$600.00 K(-114.0%) | -$2.01 M(-42.7%) |
| June 1999 | - | $4.30 M(-259.3%) | -$3.51 M(-66.3%) |
| Mar 1999 | - | -$2.70 M(-10.4%) | -$10.41 M(+6.1%) |
| Dec 1998 | -$9.81 M(+24.2%) | -$3.01 M(+43.5%) | -$9.81 M(-10.0%) |
| Sept 1998 | - | -$2.10 M(-19.2%) | -$10.90 M(+5.8%) |
| June 1998 | - | -$2.60 M(+23.8%) | -$10.30 M(+17.0%) |
| Mar 1998 | - | -$2.10 M(-48.8%) | -$8.80 M(+11.4%) |
| Dec 1997 | -$7.90 M(-1.3%) | -$4.10 M(+173.3%) | -$7.90 M(+33.9%) |
| Sept 1997 | - | -$1.50 M(+36.4%) | -$5.90 M(+1.7%) |
| June 1997 | - | -$1.10 M(-8.3%) | -$5.80 M(-18.3%) |
| Mar 1997 | - | -$1.20 M(-42.9%) | -$7.10 M(-11.3%) |
| Dec 1996 | -$8.00 M(+42.9%) | -$2.10 M(+50.0%) | -$8.00 M(+35.6%) |
| Sept 1996 | - | -$1.40 M(-41.7%) | -$5.90 M(+31.1%) |
| June 1996 | - | -$2.40 M(+14.3%) | -$4.50 M(+114.3%) |
| Mar 1996 | - | -$2.10 M | -$2.10 M |
| Dec 1995 | -$5.60 M | - | - |
FAQ
- What is Integra LifeSciences Holdings annual cash flow from operations?
- What is the all time high annual CFO for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual CFO year-on-year change?
- What is Integra LifeSciences Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly CFO year-on-year change?
- What is Integra LifeSciences Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings TTM CFO year-on-year change?
What is Integra LifeSciences Holdings annual cash flow from operations?
The current annual CFO of IART is $139.96 M
What is the all time high annual CFO for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual cash flow from operations is $312.43 M
What is Integra LifeSciences Holdings annual CFO year-on-year change?
Over the past year, IART annual cash flow from operations has changed by -$124.51 M (-47.08%)
What is Integra LifeSciences Holdings quarterly cash flow from operations?
The current quarterly CFO of IART is $22.48 M
What is the all time high quarterly CFO for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly cash flow from operations is $91.29 M
What is Integra LifeSciences Holdings quarterly CFO year-on-year change?
Over the past year, IART quarterly cash flow from operations has changed by -$4.29 M (-16.01%)
What is Integra LifeSciences Holdings TTM cash flow from operations?
The current TTM CFO of IART is $137.39 M
What is the all time high TTM CFO for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high TTM cash flow from operations is $323.41 M
What is Integra LifeSciences Holdings TTM CFO year-on-year change?
Over the past year, IART TTM cash flow from operations has changed by -$29.15 M (-17.50%)